 |
Mary Helen Barcellos-Hoff, Ph.D.Professor, Vice Chair, Research,
|
Professional Focus
Dr. Barcellos-Hoff’s research focuses on how tissues integrate information across scales of organization and uses this information to identify critical events in terms of effects on cell phenotype and tissue interaction during radiation carcinogenesis. To assess the relevance of these effects, Dr. Barcellos-Hoff developed a novel model in which irradiated mice with transplanted, unirradiated oncogenically primed mammary epithelial cells. Host radiation both accelerates tumorigenesis and affects the type of tumor, promoting those that are more aggressive. This model offers novel insight into the carcinogenic process. Identifying which specific tissue alterations contribute to the action of IR may provide means to inhibit its carcinogenic potential, plus a better understanding of how tissues suppress carcinogenesis.
A main focus has been to understand biology of transforming growth factor β (TGFβ), which is activated in irradiated cells and tissues, in normal mammary gland development and its contribution to radiation responses of tissues and tumors. In normal epithelial cells, TGFβ controls proliferation and mammary lineage commitment. In irradiated epithelial cells, TGFβ affects epithelial phenotypic stability, centrosome regulation and genomic stability. Dr. Barcellos-Hoff’s laboratory demonstrated that TGFβ is essential for epithelial cells to mount the canonical DNA damage response. The requirement for TGFβ in the genotoxic stress program provides a link between cell fate and tissue integrity and underscores interaction between target cells and other cell types.
The requirement for TGFβ in the genotoxic stress program also provided a previously unsuspected avenue to modulate radiotherapy by using concurrent treatment with TGFβ inhibitors and radiation in preclinical breast, brain and lung cancer models to increase radiation sensitivity and tumor control.
Education
| 1978 | The University of Chicago | BA | Biopsychology |
| 1986 | University of California, San Francisco | PhD | Experimental Pathology |
| 1986-88 | University of California, Berkeley | Postdoctoral | Cell Biology |
Professional Experience
| 2015-present | University of California, San Francisco | Professor, Vice Chair, Research Dir. of Radiation Biology |
Department of Radiation Oncology |
| 2010-2015 | New York University, School of Medicine | Professor (with tenure) | Departments of Radiation Oncology and Cell Biology |
| 2008-2015 | New York University, School of Medicine | Dir. of Radiation Biology | Department of Radiation Oncology |
| 2008-2010 | New York University, School of Medicine | Associate Professor | Department of Radiation Oncology |
| 2005-2008 | Lawrence Berkeley National Laboratory, University of California, Berkeley |
Deputy Division Director | Life Sciences Division |
| 2004-2008 | Lawrence Berkeley National Laboratory, University of California, Berkeley |
Department Head |
Cancer and Systems Biology |
| 2004-2008 | Lawrence Berkeley National Laboratory, University of California, Berkeley |
Senior Scientist | Life Sciences Division |
| 2001-2003 | Lawrence Berkeley National Laboratory, University of California, Berkeley |
Department Head (acting |
Cells and Molecular Biology |
| 1999-2003 | Lawrence Berkeley National Laboratory, University of California, Berkeley |
Group Leader | Cancer and Tissue Biology |
| 1988-2003 | Lawrence Berkeley National Laboratory, University of California, Berkeley |
Staff Biologist | Life Sciences Division |
| 1988 | School of Medicine, University of California, Davis | Postgraduate Researcher | Department of Anatomy |
| 1986-1988 | University of California, Berkeley | Postdoctoral Fellow | Biophysics Training Program |
| 1982-1986 | University of California, San Francisco | Research Assistant | Department of Neurological Surgery |
Recent Significant Publications :
Kleinberg DL, Barcellos-Hoff MH. The pivotal role of insulin-like growth factor I in normal mammary development. Endocrinol Metab Clin North Am. 2011 Sep;40(3):461-71, vii. PMID: 21889714
Barcellos-Hoff MH. What is the use of systems biology approaches in radiation biology? Health Phys. 2011 Mar;100(3):272-3. PMID: 21595065
Nguyen DH, Martinez-Ruiz H, Barcellos-Hoff MH. Consequences of epithelial or stromal TGFβ1 depletion in the mammary gland. J Mammary Gland Biol Neoplasia. 2011 Jun;16(2):147-55. Epub 2011 May 17. PMID: 21590374
Nguyen DH, Oketch-Rabah HA, Illa-Bochaca I, Geyer FC, Reis-Filho JS, Mao JH, Ravani SA, Zavadil J, Borowsky AD, Jerry DJ, Dunphy KA, Seo JH, Haslam S, Medina D, Barcellos-Hoff MH. Radiation acts on the microenvironment to affect breast carcinogenesis by distinct mechanisms that decrease cancer latency and affect tumor type. Cancer Cell. 2011 May 17;19(5):640-51.PMID: 21575864
Barcellos-Hoff MH. TGFβ biology in breast: 15 years on. J Mammary Gland Biol Neoplasia. 2011 Jun;16(2):65-6. PMID: 21534008
Barcellos-Hoff MH, Brenner DJ, Brooks AL, Formenti S, Hlatky L, Locke PA, Shore R, Tenforde T, Travis EL, Williams J. Low-dose radiation knowledge worth the cost. Science. 2011 Apr 15;332(6027):305-6. PMID: 21493843
Andarawewa KL, Costes SV, Fernandez-Garcia I, Chou WS, Ravani SA, Park H, Barcellos-Hoff MH. Lack of radiation dose or quality dependence of epithelial-to-mesenchymal transition (EMT) mediated by transforming growth factor β. Int J Radiat Oncol Biol Phys. 2011 Apr 1;79(5):1523-31. PMID: 21310544
Fernandez-Gonzalez, R., Illa-Bochaca, I., Welm, B. E., Fleisch, M. C., Werb, Z., Ortiz-de-Solorzano, C. and Barcellos-Hoff, Mapping mammary gland architecture using multi-scale in situ analysis. M. H. (2009). Integr Biol 1, 80 - 89. PMID: 20023794
Maxwell, C. A., Fleisch, M. C., Costes, S. V., Erickson, A. C., Boissiere, A., Gupta, R., Ravani, S. A., Parvin, B. and Barcellos-Hoff, Targeted and nontargeted effects of ionizing radiation that impact genomic instability. M. H. (2008). Cancer Res 68, 8304-8311. PMID: 18922902
Kirshner, J., Jobling, M. F., Pajares, M. J., Ravani, S. A., Glick, A., Lavin, M., Koslov, S., Shiloh, Y. and Barcellos-Hoff, M. H. (2006). Inhibition of TGFb1 signaling attenuates ATM activity in response to genotoxic stress. Cancer Res 66, 10861-68. PMID: 17090522